Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,266 public trials 445 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials

NCT03337906

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • Bridge HIV CRS San Francisco, California, United States
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • UIC Project WISH CRS Chicago, Illinois, United States
View all 21 locations
View Trial Details
Completed

Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based Settings

NCT03343925

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +16 more
Locations
  • St Vincent's Hospital Darlinghurst, New South Wales, Australia
  • Nepean Hospital Kingswood, New South Wales, Australia
  • Drug and Alcohol Services (Hunter) Newcastle, New South Wales, Australia
  • Infectious Diseases Clinic, Royal Adelaide Hospital Adelaide, South Australia, Australia
View Trial Details
Completed

Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection

NCT03403569

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou, Fujian, China
  • The Eighth People's Hospital of Guangzhou Guangzhou, Guangdong, China
  • The Fourth Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China
  • The Sixth People's Hospital of Zhengzhou Zhengzhou, Henan, China
View Trial Details
Completed

Follow-up of HBsAg Inactive Carriers Study

NCT02247752

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Ch General Du Pays D'Aix Aix-en-Provence, France
  • CH d'AVIGNON Avignon, France
  • Clinique de La Chataigneraie Beaumont, France
  • Medical Center Besancon Besançon, France
View all 32 locations
View Trial Details
Completed

Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth

NCT02428491

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations
  • Preventive Medicine Centre of Thai Binh Province Thái Bình, Vietnam
View Trial Details

Related conditions